| Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study A Dennis, M Wamil, J Alberts, J Oben, DJ Cuthbertson, D Wootton, ... BMJ open 11 (3), e048391, 2021 | 558 | 2021 |
| Inhibition of 11ß-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target M Wamil, JR Seckl Drug discovery today 12 (13-14), 504-520, 2007 | 234 | 2007 |
| Anti-inflammatory effects of nicotinic acid in human monocytes are mediated by GPR109A dependent mechanisms JE Digby, F Martinez, A Jefferson, N Ruparelia, J Chai, M Wamil, ... Arteriosclerosis, thrombosis, and vascular biology 32 (3), 669-676, 2012 | 227 | 2012 |
| Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual … K Rahimi, Z Bidel, M Nazarzadeh, E Copland, D Canoy, M Wamil, J Majert, ... The lancet 398 (10305), 1053-1064, 2021 | 181 | 2021 |
| Multi-organ impairment in low-risk individuals with long COVID A Dennis, M Wamil, S Kapur, J Alberts, AD Badley, GA Decker, SA Rizza, ... medrxiv, 2020.10. 14.20212555, 2020 | 144 | 2020 |
| Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis M Nazarzadeh, Z Bidel, D Canoy, E Copland, M Wamil, J Majert, ... The Lancet 398 (10313), 1803-1810, 2021 | 95 | 2021 |
| Novel fat depot–specific mechanisms underlie resistance to visceral obesity and inflammation in 11β-hydroxysteroid dehydrogenase type 1–deficient mice M Wamil, JH Battle, S Turban, T Kipari, D Seguret, R de Sousa Peixoto, ... Diabetes 60 (4), 1158-1167, 2011 | 77 | 2011 |
| A polygenic model of the metabolic syndrome with reduced circulating and intra-adipose glucocorticoid action NM Morton, V Densmore, M Wamil, L Ramage, K Nichol, L Bunger, ... Diabetes 54 (12), 3371-3378, 2005 | 77 | 2005 |
| 7-Oxysterols modulate glucocorticoid activity in adipocytes through competition for 11β-hydroxysteroid dehydrogenase type M Wamil, R Andrew, KE Chapman, J Street, NM Morton, JR Seckl Endocrinology 149 (12), 5909-5918, 2008 | 61 | 2008 |
| Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis M Nazarzadeh, Z Bidel, D Canoy, E Copland, DA Bennett, A Dehghan, ... The Lancet Diabetes & Endocrinology 10 (9), 645-654, 2022 | 39 | 2022 |
| Cardiac impairment in Long Covid 1-year post-SARS-CoV-2 infection A Roca-Fernández, M Wamil, A Telford, V Carapella, A Borlotti, ... medRxiv, 2022.04. 03.22272610, 2022 | 37* | 2022 |
| Increased risk of incident heart failure and death is associated with insulin resistance in people with newly diagnosed type 2 diabetes: UKPDS 89 M Wamil, RL Coleman, AI Adler, JJV McMurray, RR Holman Diabetes Care 44 (8), 1877-1884, 2021 | 35 | 2021 |
| Multi-organ impairment in low-risk individuals with long COVID. medRxiv. 2020 A Dennis, M Wamil, S Kapur, J Alberts, AD Badley, GA Decker, SA Rizza, ... preprint 14, 2020 | 31 | 2020 |
| Combined T1-mapping and tissue tracking analysis predicts severity of ischemic injury following acute STEMI—an Oxford Acute Myocardial Infarction (OxAMI) study M Wamil, A Borlotti, D Liu, A Briosa e Gala, A Bracco, M Alkhalil, ... The International Journal of Cardiovascular Imaging 35, 1297-1308, 2019 | 18 | 2019 |
| Blood pressure lowering treatment Trialists’ collaboration M Nazarzadeh, Z Bidel, D Canoy, E Copland, M Wamil, J Majert, ... Blood pressure lowering and risk of new-onset type 2, 1803-1810, 0 | 18 | |
| Synthesis, structure and tumour necrosis factor-α production-enhancing properties of novel adamantylamino heterocyclic derivatives JK MAURIN, W LASEK, A GORSKA, T SWITAJ, M WAMIL, ... Anti-cancer drug design 16 (2-3), 73-80, 2001 | 16 | 2001 |
| Multiorgan impairment in lowrisk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021; 11: e048391 A Dennis, M Wamil, J Alberts, J Oben, DJ Cuthbertson, D Wootton J Magn Reson Imaging 53, 1723-1729, 2021 | 9 | 2021 |
| Multi-modality cardiac imaging in the management of diabetic heart disease M Wamil, M Goncalves, A Rutherford, A Borlotti, PA Pellikka Frontiers in Cardiovascular Medicine 9, 1043711, 2022 | 7 | 2022 |
| Low-density lipoprotein cholesterol treatment and outcomes in patients with type 2 diabetes and established cardiovascular disease: insights from TECOS GM De Ferrari, SR Stevens, G Ambrosio, S Leonardi, PW Armstrong, ... American heart journal 220, 82-88, 2020 | 5 | 2020 |
| Multi-organ impairment in low-risk individuals with long COVID. 2020 A Dennis, M Wamil, S Kapur Preprint, 0 | 5 | |
Amitava BanerjeeProfessor of Clinical Data Science, University College London; and Honorary Consultant Cardiologist在 ucl.ac.uk 的电子邮件经过验证
